Global antimicrobial resistance alerts and implications: Introduction

Clinical Infectious Diseases

Volumn 41, Issue 4 SUPPL., 2005, Pages

  Levy, Stuart B ^a   O'Brien, Thomas F ^b,c  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; BETA LACTAMASE; CHLOROQUINE; TUBERCULOSTATIC AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; DEVELOPING COUNTRY; DRUG INDUSTRY; EDITORIAL; EPIDEMIC; ESCHERICHIA COLI; GOVERNMENT; HEALTH CARE FINANCING; HEALTH EDUCATION; HUMAN; INFECTION; KLEBSIELLA; MALARIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PUBLIC HEALTH; STREPTOCOCCUS PNEUMONIAE; TEACHING HOSPITAL; TUBERCULOSIS; VIRULENCE;

ANTI-BACTERIAL AGENTS; COMMUNICABLE DISEASES; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE; HUMANS; INTERNATIONAL COOPERATION; WORLD HEALTH;

EID: 23244451969     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/432443     Document Type: Editorial

References (8)

1. Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerg Infect Dis 2005; 11:873-82.
2. Alliance for the Prudent Use of Antibiotics. Antibiotic resistance: synthesis of recommendations by expert policy groups. Geneva: World Health Organization, 2001.
3. House of Lords United Kingdom. Resistance to antibiotics and other antimicrobial agents: 7th report of the House of Lords' Select Committee on Science and Technology, 1997-1998. London: The Stationary Office, 1998.
4. Department of Health United Kingdom. The path of least resistance: main report of the Standing Medical Advisory Committee, Sub-Group on Antimicrobial Resistance. London: Department of Health, 1998.
5. O'Brien TF. Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin Infect Dis 2002; 34(Suppl 3):S78-84.
6. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004; 10(Suppl 12):S122-9.
7. World Health Organization (WHO). Global strategy for containment of antimicrobial resistance. Geneva: WHO, 2001.
8. Alliance for the Prudent Use of Antibiotics. Shadow epidemic: the growing menace of drug resistance. Executive summary of the 2005 GAARD report. Boston: APUA, 2005.